镇江过敏性紫癜好治六安过敏性紫癜经常复发怎么办,巢湖过敏性紫癜怎么治疗好得快,扬州哪里过敏性紫癜医院好,淮北紫癜治疗,绍兴过敏性紫癜挂什么科,赣州哪个医院治疗过敏性紫癜好,绍兴过敏性紫癜病

BEIJING, March 11(Xinhuanet)-- People with more fat around their waist, often known as “apple shape”, may not have a greater risk of heart attack than those with fatter bottoms and hips, according to a new study published in Lancet as quotted by media reports Friday.This study funded by the Medical Research Council and British Heart Foundation, reviewed 220,000 individual records from 17 countries and monitored the occurrence of heart attacks or strokes based on body mass index (BMI) versus waist-hip circumference. It found that people with "apple-shaped" obesity were at a higher risk of having heart risks compared to those with general obesity as assessed by their BMI.  This contradicts previous claims that "apple shaped" bodies were three times more likely to suffer heart attacks than those with more generally distributed fat.But experts warn obesity is still bad for the heart, no matter where the fat is, and they argue there is confusion about the best way to measure it. "Regardless of how you measure it, being obese is bad for your heart. This study suggests that measuring your waist is no better than calculating your BMI but it's not time to throw away the tape measure just yet, “Dr Mike Knapton, associate medical director at the British Heart Foundation said."We tend to underestimate our body shape and size, so measuring our waist or checking our BMI are both quick and easy ways we can check our health at home."Besides, he also listed some other heart risk factors that we need to think about too, such as blood pressure, cholesterol, diabetes and smoking.

MOSCOW, Jan. 21 (Xinhua) -- Russian and Chinese companies started construction of an iron ore dressing plant Friday in the Evreyskaya Autonomous Oblast to provide high-grade iron ore to the Asia Pacific region, including China.Yury Makarov, chief executive officer of IRC Ltd., told Xinhua the plant would reach its designed capacity in 2013 at 10 million tons of iron ore and 3.2 million tons of iron ore concentrates, which contain up to 65 percent iron.Makarov said that 20 percent of the iron ore concentrates, which are natural iron ore processed through crushing, grinding and dressing, would be used to meet demands of Russia's far east and the rest would go to the Asia-Pacific market. Currently, China imports large amounts of concentrates from Brazil, Australia and India."We are very open to interaction with various countries of the Asia-Pacific region, especially China. The volume of processed iron ore has been increasing every year. We will be happy to deliver iron ore to your companies as well as any other consumers who are willing to purchase our products," he said.The plant will draw its resources from the Kimkanskoye and Sutarskoye deposits and send its products through the Khabarovsk Krai and the Suifenhe port to China.The plant is only 7 km from the Trans-Siberian Railway. A railway bridge is being planned between Evreyskaya Oblast and Heilongjiang to further shorten the supply route.Total investment in the plant is 400 million U.S. dollars, with 340 million in loans from the ICBC (Industrial and Commercial Bank of China) in China. Interest under the facility will be charged at 2.8 percent above LIBOR per annum. The China National Electric Engineering Co, Ltd is tasked with the construction of the plant.Makarov said he was very optimistic about the future of the plant and the development of relations between the Russia's far east and China's northeastern region.IRC Ltd. is a metal unit of Russian gold miner Petropavlovsk PLC. It became the second Russian company to be listed on the HK stock exchange, when it started trading on Oct. 21.

BEIJING, May 24 (Xinhuanet) -- The PlayStation Network's shutdown caused by hacker's attack has cost Sony 14 billion Japanese yen, or 171 million U.S. dollars.Sony revealed the figure on Monday as a part of its overall loss in the massive earthquake and tsunami, 3.2 billion U.S. dollars, in the company's fiscal year ending on March 31, 2011.The 171 million U.S. dollars cover the lost revenue, the customer compensations, the security and legal enhancement fees and the free games the company offered as a goodwill gesture.The cyber-attacks, which kept the PlayStation Network offline from April 20 to May 15, involved the theft of personal data from more than 100 million accounts of the gamers.But the crisis was far from over yet."So far, we have not received any confirmed reports of customer identity theft issues, nor confirmed any misuse of credit cards from the cyber-attack," the company said, "Those are key variables, and if that changes, the costs could change."

YANGON, May 6 (Xinhua) -- A five-day Myanmar traditional medicine exhibition is underway in Myanmar's former capital of Yangon beginning Thursday, aimed at promoting the development of the country's traditional medicines and disseminating medical knowledge to the public.With over 120 booths, traditional medicine producing companies are displaying their traditional medicine products and producing accessories as well as giving traditional treating service and medical education talks.As the Myanmar traditional medicine is playing a more and more important role in treating diseases in the country, the government urges traditional medicine practitioners to protect and preserve them from depletion and extinction and to ensure their perpetual existence.Myanmar is conducting research on treatment of major diseases -- diabetes, hypertension, malaria, tuberculosis, diarrhea and dysentery through traditional medicine.To do research more effectively and on a wider scale to have the Myanmar traditional medicine standardized, the country holds traditional medicine practitioners conference every year to introduce the country's traditional medicines and its medical practices and the last conference, which was the 11th, took place in Nay Pyi Taw in December 2010.At the same time, the practitioners are also urged to strive for the promotion of the standard of Myanmar traditional medicine to reach international level.

WASHINGTON, April 3 (Xinhua) -- In the largest study of its kind, researchers from a consortium led by the University of Pennsylvania School of Medicine, the University of Miami, and the Boston University School of Medicine, identified four new genes linked to Alzheimer's disease. The findings appeared Sunday in the current issue of Nature Genetics.Each gene individually adds to the risk of having this common form of dementia later in life. These new genes offer a portal into what causes Alzheimer's disease and is a major advance in the field.The study, conducted by the Alzheimer's Disease Genetics Consortium, reports genetic analysis of more than 11,000 people with Alzheimer's disease and a nearly equal number of elderly people who have no symptoms of dementia. Three other consortia contributed confirming data from additional people, bringing the total number of people analyzed to over 54,000. The consortium also contributed to the identification of a fifth gene reported by other groups of investigators from the United States, the United Kingdom, France, and other European countries.The study is the result of a large collaborative effort with investigators from 44 universities and research institutions in the United States, led by Gerard Schellenberg at University of Pennsylvania."This is the culmination of years of work on Alzheimer's disease by a large number of scientists, yet it is just the beginning in defining how genes influence memory and intellectual function as we age. We are all tremendously excited by our progress so far, but much remains to be done, both in understanding the genetics and in defining how these genes influence the disease process," Schellenberg said.Until recently, only four genes associated with late-onset Alzheimer's have been confirmed, with the gene for apolipoprotein E-e4, APOE-e4, having the largest effect on risk. The Nature Genetics studies add another four -- MS4A, CD2AP, CD33, and EPHA1 -- and contribute to identifying and confirming two other genes, BIN1 and ABCA7, thereby doubling the number of genes known to contribute Alzheimer's disease.